Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News VentriPoint Diagnostics Ltd VPTDF


Primary Symbol: V.VPT

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

Recent & Breaking News (TSXV:VPT)

Ventripoint to Sponsor Advanced Imaging 2023 in London, England

TheNewsWire July 11, 2023

Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany

TheNewsWire July 5, 2023

Ventripoint Receives European Union Medical Device Regulation Certification

TheNewsWire May 30, 2023

Ventripoint Announces Date and Webinar Details Regarding First Quarter 2023 Financial Results

TheNewsWire May 29, 2023

Ventripoint Issues Option Grants and Reports Exercise of Options

TheNewsWire May 17, 2023

Ventripoint Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

TheNewsWire May 2, 2023

Ventripoint Announces Sponsorship of the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology

TheNewsWire April 25, 2023

Ventripoint Diagnostics Provides a Corporate Update

TheNewsWire March 16, 2023

Ventripoint Diagnostics Announces Dr. Alvira Macanovic as President and CEO

TheNewsWire January 2, 2023

Ventripoint Diagnostics Provides a Corporate Update and Announces New Investor Relations Initiative

TheNewsWire December 14, 2022

Ventripoint Signs on Arc Group Medical LLC as Distributor in Florida Region

TheNewsWire November 30, 2022

Ventripoint Appoints MediTek Lifesciences LLC as Distributor for California

TheNewsWire November 17, 2022

Ventripoint to Sponsor the Annual Meeting of the British Congenital Cardiac Association

TheNewsWire November 4, 2022

Ventripoint Diagnostics Provides a Corporate Update and Announces New Investor Relations Initiative

TheNewsWire October 27, 2022

Ventripoint Diagnostics (TSXV:VPT) exhibiting at the 2022 British Society of Echocardiography

Shoran Devi October 14, 2022

Ventripoint Diagnostics Exhibiting at the 2022 British Society of Echocardiography

TheNewsWire October 14, 2022

Ventripoint (TSXV:VPT) announces sponsorship for the European Society of Cardiology congress

Shoran Devi August 26, 2022

Ventripoint Announces Sponsorship for the European Society of Cardiology Congress 2022

TheNewsWire August 26, 2022

Echocardiologists in Latin America Express Strong Interest in Ventripoint Whole Heart Analysis Products

TheNewsWire August 10, 2022

Single Ventricle Congenital Heart Disease Study Launches at Leading Academic Medical Center using Ventripoint's VMS+3.0 Whole-Heart Analysis System

TheNewsWire June 29, 2022